IDEAYA Biosciences IDYA
NASDAQ IDYA
$37.55 -0.26 (-0.69%)
As of: Oct 2, 2026 · 1:28 PM EDT

IDEAYA Biosciences (IDYA) Depreciation & Amortization (CF) (2018 - 2026)

Updated

IDEAYA Biosciences' Depreciation & Amortization (CF) was $688,000 in Q2 2026, down 4.2% from $718,000 a year earlier and unchanged from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, IDEAYA Biosciences' Depreciation & Amortization (CF) was $2.76 million through Jun 30, 2026, up 11.8% year-over-year; for FY2025, it came in at $2.7 million, up 13.1% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $2.39 million in FY2024 (-3.6%), $2.48 million in FY2023 (+17.8%), $2.1 million in FY2022 (+21.8%) and $1.73 million in FY2021 (+24.9%).
  • Quarterly Depreciation & Amortization (CF) has moved between $448,000 (Q4 2021) and $721,000 (Q4 2025) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in four of the last eight quarters, with growth averaging 5.6%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2021 (growth of 30.0%); the worst was Q3 2024 (a decline of 9.8%).
  • Per Business Quant data, IDYA's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $688,000 (Q1 2026), $721,000 (Q4 2025) and $661,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 IDEAYA Biosciences 3.70 Bn 776.31 Mn - 688,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 688,000.00
Mar 31, 2026 688,000.00
Dec 31, 2025 721,000.00
Sep 30, 2025 661,000.00
Jun 30, 2025 718,000.00
Mar 31, 2025 600,000.00
Dec 31, 2024 572,000.00
Sep 30, 2024 577,000.00
Jun 30, 2024 622,000.00
Mar 31, 2024 616,000.00
Dec 31, 2023 629,000.00
Sep 30, 2023 640,000.00
Jun 30, 2023 619,000.00
Mar 31, 2023 588,000.00
Dec 31, 2022 558,000.00
Sep 30, 2022 569,000.00
Jun 30, 2022 510,000.00
Mar 31, 2022 464,000.00
Dec 31, 2021 448,000.00
Sep 30, 2021 451,000.00
API Access

IDEAYA Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IDYA&period=max&api_key=YOUR_API_KEY